☆ 4.7 Article

Direct Health Care Costs Associated With Multiple Sclerosis A Population-Based Cohort Study in British Columbia, Canada, 2001-2020

NEUROLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Health Care Sciences & Services

The impact of lookback windows on the prevalence and incidence of chronic diseases among people living with HIV: an exploration in administrative health data in Canada

Ni Gusti Ayu Nanditha et al.

Summary: This study examines the impact of different lengths of lookback window (LW) on the prevalence and incidence of chronic diseases. The results demonstrate the importance of carefully selecting LWs to minimize misclassification of disease cases, while also highlighting the variation in impact across diseases and populations.

BMC MEDICAL RESEARCH METHODOLOGY (2022)

Add to Collection

Article Clinical Neurology

Productivity loss among people with early multiple sclerosis: A Canadian study

Elisabet Rodriguez Llorian et al.

Summary: This study analyzed work productivity loss and costs among employed people with multiple sclerosis (pwMS) in Canada, as well as its association with clinical, sociodemographic, and work-related factors. The results showed that pwMS experienced significant productivity loss and costs, with fatigue being a key factor contributing to the loss.

MULTIPLE SCLEROSIS JOURNAL (2022)

Add to Collection

Article Economics

Effectiveness and Cost-Effectiveness of 360 Disease-Modifying Treatment Escalation Sequences in Multiple Sclerosis

Matthijs M. Versteegh et al.

Summary: This study compared 360 different treatment sequences for patients with relapsing-remitting multiple sclerosis (RRMS) in terms of health outcomes and societal costs. The results showed that the optimal treatment sequence for maximizing health outcomes was not necessarily the most cost-effective option. Treatment decisions should be individually tailored.

VALUE IN HEALTH (2022)

Add to Collection

Review Health Care Sciences & Services

Cost of illness in multiple sclerosis by disease characteristics - A review of reviews

Dirk Schriefer et al.

Summary: Through a review of cost-of-illness studies in multiple sclerosis, it was found that costs increased with disability level, relapse episodes, and disease progression. As disability worsened, the share of costs outside the health system gradually outweighed the share of direct medical costs.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates

Kristina Malene Odegaard et al.

Summary: The study evaluated the impact of lookback periods on heart failure incidence rates and identified 6 years of fixed lookback as adequate for identifying incident heart failure cases. The research found that from 2014 to 2018, there was an increasing trend in heart failure incidence rates and prevalence.

BMC CARDIOVASCULAR DISORDERS (2022)

Add to Collection

Article Clinical Neurology

The Economic Burden of Multiple Sclerosis in the United States Estimate of Direct and Indirect Costs

Bruce Bebo et al.

Summary: This study estimates the total economic burden of multiple sclerosis (MS) in the United States in 2019. The findings show that MS has a significant impact on various aspects of patients' lives, including work, physical independence, and social interaction. The study highlights the high cost of prescription drugs and the indirect loss of productivity as important drivers of the economic burden of MS.

NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Closing the Part D Coverage Gap and Out-of-Pocket Costs for Multiple Sclerosis Drugs

Daniel M. Hartung et al.

Summary: The study found that closing the Part D coverage gap did not reduce out-of-pocket costs for MS patients due to simultaneous increases in DMT prices.

NEUROLOGY-CLINICAL PRACTICE (2021)

Add to Collection

Review Clinical Neurology

Health economics of disease-modifying therapy for multiple sclerosis in the United States

Daniel M. Hartung

Summary: Multiple sclerosis (MS) is a chronic neuroinflammatory condition that is associated with significant disability. The high and rising prices of disease-modifying therapies (DMTs) for MS are a major driver of healthcare expenditures. The cost burden of DMTs negatively affects both healthcare systems and patients.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)

Add to Collection

Article Health Care Sciences & Services

The effects of different lookback periods on the sociodemographic structure of the study population and on the estimation of incidence rates: analyses with German claims data

Jelena Epping et al.

BMC MEDICAL RESEARCH METHODOLOGY (2020)

Add to Collection

Article Clinical Neurology

Validation of an algorithm for identifying MS cases in administrative health claims datasets

William J. Culpepper et al.

NEUROLOGY (2019)

Add to Collection

Article Clinical Neurology

Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Mitchell T. Wallin et al.

LANCET NEUROLOGY (2019)

Add to Collection

Article Health Care Sciences & Services

Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries

Kaoru Yamabe et al.

CLINICOECONOMICS AND OUTCOMES RESEARCH (2019)

Add to Collection

Review Clinical Neurology

Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA

Daniel M. Hartung

NEUROTHERAPEUTICS (2017)

Add to Collection

Article Economics

The burden of multiple sclerosis in Japan

Chiyoko Nohara et al.

JOURNAL OF MEDICAL ECONOMICS (2017)

Add to Collection

Article Respiratory System

Excess medical costs in patients with asthma and the role of comorbidity

Wenjia Chen et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Add to Collection

Review Multidisciplinary Sciences

Cost of Illness of Multiple Sclerosis - A Systematic Review

Olivia Ernstsson et al.

PLOS ONE (2016)

Add to Collection

Article Critical Care Medicine

Ten-Year Trends in Direct Costs of COPD A Population-Based Study

Amir Khakban et al.

CHEST (2015)

Add to Collection

Article Clinical Neurology

The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?

Daniel M. Hartung et al.

NEUROLOGY (2015)

Add to Collection

Article Health Care Sciences & Services

Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis

Sander Yermakov et al.

JOURNAL OF MEDICAL ECONOMICS (2015)

Add to Collection

Article Clinical Neurology

Comorbidity increases the risk of hospitalizations in multiple sclerosis

Ruth Ann Marrie et al.

NEUROLOGY (2015)

Add to Collection

Article Clinical Neurology

Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates

Jonathan D. Campbell et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2014)

Add to Collection

Article Clinical Neurology

Direct and indirect cost burden associated with multiple sclerosis relapses: Excess costs of persons with MS and their spouse caregivers

Helene Parise et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)

Add to Collection

Review Clinical Neurology

Sex and gender issues in multiple sclerosis

Hanne F. Harbo et al.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)

Add to Collection

Article Clinical Neurology

Economic Burden in a German Cohort of Patients with Multiple Sclerosis

Jens Peter Reese et al.

EUROPEAN NEUROLOGY (2011)

Add to Collection

Review Economics

REVIEW OF STATISTICAL METHODS FOR ANALYSING HEALTHCARE RESOURCES AND COSTS

Borislava Mihaylova et al.

HEALTH ECONOMICS (2011)

Add to Collection

Article Public, Environmental & Occupational Health

Socioeconomic Trends in Hospitalization for Multiple Sclerosis

Shivanand P. Lad et al.

NEUROEPIDEMIOLOGY (2010)

Add to Collection

Review Economics

Economic Burden of Multiple Sclerosis A Systematic Review of the Literature

Huseyin Naci et al.

PHARMACOECONOMICS (2010)

Add to Collection

Review Clinical Neurology

Temporal trends in the incidence of multiple sclerosis

Alvaro Alonso et al.

NEUROLOGY (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.